NDC 0409-1810 - Novocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0409-1810
- Package NDCs from labels
- 0409-1810-02
- Manufacturer
- Hospira, Inc.
- Effective date
- 2007-08-28
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| NOVOCAIN ® PROCAINE HYDROCHLORIDE INJECTION, USP | Hospira, Inc. | 2007-08-28 | Human prescription drug label |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0409-1810-02 | Novocaine | 25 in 1 CARTON | INJECTION, SOLUTION | 25 | 2 | |
| 0409-1810-02 | Novocaine | 5 in 1 CONTAINER | INJECTION, SOLUTION | 5 | 2 | |
| 0409-1810-02 | Novocaine | 40 in 1 CASE | INJECTION, SOLUTION | 40 | 2 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Procaine Hydrochloride | ACTIVE INGREDIENT | 95URV01IDQ | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Procaine | ACTIVE MOIETY | 4Z8Y51M438 | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 | |
| Acetone Sodium Bisulfite | INACTIVE INGREDIENT | NOVOCAINE (PROCAINE HYDROCHLORIDE) INJECTION, SOLUTION [HOSPIRA, INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vancomycin Hydrochloride | VANCOMYCIN HYDROCHLORIDE | Hospira, Inc. | c9ea31ec-4c26-452f-b07b-c5f894212cd5 | 2026-04-01 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | ce9a7469-c4ba-4f60-8f7a-47ef0974316e | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | c91ede49-c7cc-47b7-0f93-e6841dd5916a | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | abc41ed1-9512-4bea-9295-1a9ca134b6c2 | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Acetate | SODIUM ACETATE | Hospira, Inc. | c3be2468-45e8-4ecc-a30b-e966743a563f | 2026-03-26 | Warnings, Adverse reactions | Hospira, Inc. |
| Heparin Sodium | HEPARIN SODIUM | Hospira, Inc. | 6c181d7e-aed2-4975-30ac-d39a94cca7ec | 2026-03-24 | Warnings, Adverse reactions | Hospira, Inc. |
| Sterile Water | WATER | Hospira, Inc. | 2b9ea23a-f9e9-48a8-25b7-519e3bbd6828 | 2026-03-18 | Warnings, Adverse reactions | Hospira, Inc. |
| Rocuronium Bromide | ROCURONIUM BROMIDE | Hospira, Inc. | 309aeb1b-8022-4df7-8194-ae6529e3395c | 2026-03-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Bupivacaine Hydrochloride | BUPIVACAINE HYDROCHLORIDE | Hospira, Inc. | 02a845c3-4521-4926-e397-25ab536e7cf6 | 2026-03-09 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| SODIUM BICARBONATE | SODIUM BICARBONATE | Hospira, Inc. | 084f5572-8c1f-4802-b179-ca0cc838fc68 | 2026-03-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Chloride | SODIUM CHLORIDE | Hospira, Inc. | 018a8807-1331-41c3-4889-c7ec502a9043 | 2026-03-09 | Warnings, Adverse reactions | Hospira, Inc. |
| Sodium Bicarbonate | SODIUM BICARBONATE | Hospira, Inc. | 0c24b592-4bc8-456f-acac-9c9525844a06 | 2026-03-09 | Warnings, Adverse reactions | Hospira, Inc. |
| VinCRIStine Sulfate | VINCRISTINE SULFATE | Hospira, Inc. | b22e4c8e-dbe1-4d4b-a026-e1812974071c | 2026-02-17 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Magnesium Sulfate | MAGNESIUM SULFATE | Hospira, Inc. | e175d329-315f-4f3b-bb4c-06ad4e042967 | 2026-02-12 | Warnings, Adverse reactions | Hospira, Inc. |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | f9ca2ef5-46d8-475a-a26e-f7c8becd6db7 | 2026-02-04 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Calcium Chloride | CALCIUM CHLORIDE | Hospira, Inc. | c4c65e48-85f8-4dcf-6281-06e40959cc79 | 2026-02-02 | Warnings, Adverse reactions | Hospira, Inc. |
| Buprenorphine Hydrochloride | BUPRENORPHINE HYDROCHLORIDE | Hospira, Inc. | 23aa1bb3-cecf-4e62-29bb-48488bb66fc3 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | be420e8b-bcb0-49b5-bb4d-1df8b9959809 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Morphine Sulfate | MORPHINE SULFATE | Hospira, Inc. | ee8057d1-ed12-4e18-9efa-d83504abf612 | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
| Hydromorphone Hydrochloride | HYDROMORPHONE HYDROCHLORIDE | Hospira, Inc. | e9c9ef18-7dfc-4322-b2fc-29b934c30f8b | 2025-12-31 | Boxed warning, Warnings, Adverse reactions | Hospira, Inc. |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.